论文部分内容阅读
目的:探讨中西医结合治疗强直性脊柱炎的临床效果和安全性。方法:选取78例强直性脊柱炎患者,随机分为对照组和研究组各39例,对照组患者采用常规西医进行治疗,研究组患者采用中西医结合治疗,比较两组患者的临床治疗效果及不良反应。结果:经过治疗,研究组患者总有效率明显优于对照组,且不良反应发生率明显低于对照组,治疗满意度显著高于对照组,差异均具有统计学意义(P<0.05);两组患者治疗后的实验室指标血沉(ESR)、C反应蛋白(CRP)及免疫球蛋白(IgA)较治疗前均明显降低,与对照组治疗后比较,研究组下降更明显,组间比较差异均具有统计学意义(P<0.05)。结论:中医联合西药治疗强直性脊柱炎疗效显著,更具有针对性、安全性、可控性,不良反应少,值得临床推广应用。
Objective: To explore the clinical efficacy and safety of integrated traditional Chinese and western medicine in the treatment of ankylosing spondylitis. Methods: Seventy-eight patients with ankylosing spondylitis were randomly divided into control group and study group, 39 cases in each group. Patients in control group were treated with routine western medicine. Patients in study group were treated with combination of TCM and Western medicine. Adverse reactions. Results: After treatment, the total effective rate of the study group was significantly better than that of the control group, and the incidence of adverse reactions was significantly lower than that of the control group, the treatment satisfaction was significantly higher than that of the control group, the difference was statistically significant (P <0.05); two The ESR, C-reactive protein (CRP) and immunoglobulin (IgA) of the experimental group after treatment were significantly lower than those before treatment, the study group decreased more significantly after treatment, the difference was statistically significant All were statistically significant (P <0.05). Conclusion: Chinese medicine combined with Western medicine treatment of ankylosing spondylitis significant effect, more targeted, safety, controllability, fewer adverse reactions, worthy of clinical application.